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Abstract
Background
Physical activity at moderate-high intensity is recommended to prevent lifestyle diseases.
Patients with atrial fibrillation are at risk of a sedentary lifestyle due to fear of exercise-
induced episodes of atrial fibrillation. The burden of arrhythmia can be reduced by physical
exercise. The effect of exercise intensity on burden of atrial fibrillation needs to be studied
further.
Methods and results
In a 12-week randomized controlled trial, 76 patients with paroxysmal/persistent atrial fibril-
lation were allocated to perform exercise at either low intensity or high intensity (50% and
80% of maximal perceived exertion, respectively). Primary outcome was burden of AF mea-
sured by daily electrocardiography-reporting during 12 weeks. Secondarily, change in maxi-
mal oxygen uptake (peak VO2) and 1-year hospitalization was compared between low and
high intensity exercise. Sixty-three patients completed the follow-up. In the intention-to-treat
analysis, we found no statistical difference in burden of atrial fibrillation between low and
high intensity exercise (incidence rate ratio 0.742, 95% CI 0.29–1.91, P = 0.538). No serious
adverse events were reported and there was no difference in hospitalization between the
two exercise groups. Both exercise groups improved significantly in peak VO2 (low intensity:
3.62 mL O2/kg/min, SD 3.77; high intensity: 2.87 mL O2/kg/min, SD 4.98), with no statistical
difference between-groups (mean difference: 0.76 mL O2/kg/min, 95% CI -3.22–1.7).
Conclusions
High intensity physical exercise was not superior to low intensity physical exercise in reduc-
ing burden of atrial fibrillation. HI exercise was well tolerated; no evidence of an increased
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1. Introduction
Atrial fibrillation (AF) is the most common cardiac rhythm disturbance in the Western
World, affecting ~2% of the general population [1]. With improved survival from other cardio-
vascular disease and longer lifespan, the incidence is expected to increase even more [2]. The
arrhythmia has great impact on daily life, causing a more sedentary lifestyle due to symptoms
or fear of provoking episodes of AF [3]. A sedentary lifestyle increases the risk of cardiovascu-
lar disease, hypertension, diabetes, and obesity [4]. These conditions are all risk factors for AF,
and can possibly perpetuate AF [5–8].
In most observational studies of healthy individuals, both a sedentary lifestyle and endur-
ance exercise are associated with increased risk of incident AF [9–11]. A recent systematic
review regarding elite exercise and AF risk states a higher risk of AF among elite athletes [12],
although others argue that this is overestimated [13]. In the latest meta-analysis concerning
health benefits of physical exercise for patients with all types of AF, exercise led to improve-
ments in frequency control, lower risk of AF-relapse after ablation, and increased quality of
life [14].
Awareness has increased of using physical activity as supplementary treatment to patients
with paroxysmal/persistent atrial fibrillation (PAF). Recently, high intensity (HI) cardiovascu-
lar exercise has been shown to reduce the burden of AF compared to a passive control group
[15]. It remains unknown, if the positive effect of cardiovascular exercise on the burden of AF
is related to exercise intensity. The aim of the study was to investigate if 12 weeks of HI cardio-
vascular exercise would reduce the burden of AF more than low intensity (LI) cardiovascular
exercise in patients with PAF.
2. Methods
2.1 Study design
The study was an assessor-blinded, randomized, controlled, superiority trial, in which patients
were assigned 1:1 to a 12-week program of physical exercise at LI or HI. Assessments were per-
formed before first exercise session (baseline) and after 12 weeks (follow-up). Throughout
week 4–16, patients transmitted an electrocardiography (ECG) twice daily and in case of AF
symptoms.
The reporting of the study follows the Consolidated Reporting of Reporting of Trials
(CONSORT), using the extension for non-pharmacological trials [16] (S1 CONSORT Check-
list), and the reporting of the exercise intervention follows the Template for Intervention
Description and Replication checklist (TIDieR) [17]. The present study was developed in
accordance with the Declaration of Helsinki and has approval from the National Committee
on Health Research Ethics (H-2-2012-048). All patients gave their written informed consent,
and the trial was registered at ClinicalTrials.Gov, March 2013 (NCT01817998), https://
clinicaltrials.gov/ct2/show/NCT01817998
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2.2 Participants
Patients were included, using consecutive sampling, from The Department of Cardiology at
Copenhagen University Hospital, Amager and Hvidovre, in the time period 2013–15. Possible
eligible patients were found by screening lists of admissions from the cardiology ward and the
cardiology out-patient clinics at the two hospitals. Eligibility criteria were admission with
International Classification of Disease (ICD)-10 codes Z035A (suspected arrhythmia), I489
(atrial fibrillation or flutter unspecified), R002 (palpitations), Z035 (suspected cardiovascular
disease), I471 (supraventricular tachycardia with narrow QRS-interval), R008A (cardiac
arrhythmia unspecified), and I480 (paroxysmal atrial fibrillation). Medical journals were
reviewed according to inclusion and exclusion criteria, and eligible patients offered participa-
tion by mail or telephone.
Inclusion criteria were paroxysmal or persistent AF (PAF) documented on ECG, age18
years, and written informed consent. Exclusion criteria were permanent AF, substantial lan-
guage barrier, severe health conditions making physical exercise impossible, life expectancy
shorter than one year, or signs of cardiac disease during baseline tests.
2.3 Randomization
2.3.1. Sequence generation. After stratification for sex, patients were randomly assigned
1:1 to either LI or HI exercise using a simple shuffling envelopes procedure. All patients were
assigned with a unique identification number. Each identification number was assigned ran-
domly with the letter A or B, by drawing from an opaque envelope. Until the first exercise ses-
sion, a note revealing which intensity each letter represented was kept in a sealed envelope.
The physiotherapists conducting the exercise sessions were allocated to a group before the
randomization.
2.3.2. Allocation concealment and implementation. To ensure concealment, randomi-
zation was generated by an employee at the hospital with no connection to the trial. The phys-
iotherapists received the envelope revealing the exercise intensity at the first session.
2.4 Blinding
All assessors and analysts were blinded to the intervention allocation. Patients were blinded to
the study hypothesis, and they were not informed of what intervention they were receiving,
but it is highly possible that they were able to figure it out. They were informed not to reveal
any detail about their exercise group when performing follow-up tests, to preserve blinding of
the research team. All data was registered in an anonymous database by the patients’ identifi-
cation number.
2.5 Intervention
Over 12 weeks, supervised exercise sessions of 60 minutes each were conducted twice weekly
at The Department of Physiotherapy, Copenhagen University Hospital, Amager and Hvidovre.
To ensure close supervision of the patients during exercise, the participants were subdivided
into small groups of ten patients exercising with one physiotherapist. Exercise was planned by
experienced cardiac rehabilitation physiotherapists.
Intensity was measured on the Borg scale (Rating of Perceived Exertion 1–20) [18] to adjust
for individual physical improvement and to avoid using heart rate as measuring scale. Borg-20
scale is valid for measuring exercise intensity and ensures standardization of the exercise pro-
gram so each individual exercise at the same relative intensity [18,19]. Assessing exercise inten-
sity with heart rate could be inaccurate in patients receiving medical frequency control or in
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case a patient had AF during exercise. LI exercise was defined as 50% of maximum perceived
exertion (Borg 11–13) and HI as 80% of maximum perceived exertion (Borg 16–18). Each
exercise session consisted of 10 min warm up (Borg 7–10), 20 min interval exercising on
ergometer bike (with allocated intensity), 20 min varying circuit exercise on the floor (with
allocated intensity), and 10 min cool down. Exercise intensity progressed gradually over the
first five weeks; during week 1 the patients got familiar with using the Borg scale for adjust-
ment of exercise intensity, and during week 2–5 biking, walking, and circuit exercises were
introduced, and exercise intensity increased weekly until reaching the scheduled 50% and
80% of maximum, respectively. Intensity remained constant during week 6–12, and volume
increased substantially. The complete exercise program is specified in S1 Appendix A.
2.6 Outcomes
At baseline and follow-up, blinded assessments were performed by trained medical personnel.
Patients had an advanced echocardiography, a 24-hour measurement of blood pressure and
heart rate, cardiopulmonary exercise test (CPET) for measuring maximal oxygen uptake (peak
VO2) and a questionnaire of previous medical history.
2.6.1 Descriptives. Demographic variables were age (years), sex, ethnicity (white or
other), height (cm), BMI (kg/m2), smoking (yes, no, former), and alcohol (men:14 or >14
units of alcohol weekly, women: 7 or > 7 units of alcohol weekly). Medical history was
obtained by self-reported questionnaire and verified in medical records; type of AF (paroxys-
mal, persistent), time since diagnosis of AF (months), hypertension, diabetes, ischemic heart
disease, metabolic disease, chronic obstructive pulmonary disease, heart failure, and daily car-
diac medication. Left ventricular ejection fraction (LVEF, %), left atrial volume index (LA vol-
ume, mL/m2), and left ventricular internal diameter end diastolic (LViDd, cm) were measured
by echocardiography. Significant heart valve disease and pulmonary hypertension were noted
if present. Blood pressure (mmHg) and heart rate (bpm) measured for 24 hours were pre-
sented as mean systolic and diastolic values during day time and night time. Overall exercise
participation was assessed as percentage participation.
Echocardiography was performed by a cardiologist to rule out structural cardiac disease,
using Philips iE33, Philips Medical System 6.0.2.144. LA volume and LVEF were assessed
using the modified Simpson’s method, estimating the average volumes from apical two- and
four- chamber views.
Assessment of blood pressure and heart rate was performed by laboratory technicians using
ScottCare ABP 320, CardioView Dx 4.0.8, and Rozinn RZ153+, software edition v10.6, respec-
tively. Echocardiography was analyzed by a cardiologist in accordance with European standard
guidelines [20].
2.6.2 Primary outcome. The primary efficacy outcome was burden of AF in the time
period from week 4 to week 16 of exercise. It was calculated as the ratio of ECGs with AF and
total number of ECGs (ECGAF/ECGtotal).
ECG was measured using a patient-triggered handheld ECG-device (Zenicor1), software
edition 3.0. Diagnosis with AF was defined as minimum 10 s of coherent irregular rhythm and
lack of a defined p-wave ahead of each QRS-complex. Analysis was performed independently
twice by a physician and evaluated by a blinded cardiologist in case of questionable diagnosis.
ECGs not possible to diagnose unambiguously were excluded from analysis. Sensitivity (96%)
and specificity (92%) regarding AF has been determined previously [21].
2.6.3 Secondary outcomes. The secondary outcomes were change in peak VO2 and over-
all hospital admissions.
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Change in peak VO2 was measured from baseline to follow-up (week 12) to assess the effect
on physical fitness of LI and HI exercise, respectively. CPETs were performed on ergometer
bike protocolled with three min warm up followed by stepwise increase in load. Two trained
assistants executed the test and analyzed ECG-monitoring and blood pressure continuously.
The test was considered valid at complete exhaustion with respiratory exchange rate (ReR)
1.0. In case of any adverse events during CPET, the test was interrupted instantly. Maximal
exercise capacity was termed peak VO2 as recommended when testing non-healthy subjects
[22].
Peak VO2 (mL O2/min/kg) was measured with breath-by-breath gas analysis using CosMed
K4 b21. Calibration procedure was performed as specified in the manual in reference to
humidity, ambient temperature, and barometric pressure; room air calibration was performed
before each test, delay and gas calibration daily, volume calibration weekly. Raw data was pro-
cessed by running 8-breath averaging (mean) and peak VO2 determined as the maximum
value within the last 60 s of the test [23].
Hospital admissions were assessed from baseline (week 1) to one year after last exercise ses-
sion. Electronic medical records were reviewed twice by two independent reviewers for admis-
sions caused by recurrent AF verified on ECG, heart failure, stroke, radio frequency ablation,
surveillance for medical antiarrhythmic treatment, or pacemaker implantation. Death of any
cause was reported.
All patients were evaluated for adverse events during the intervention period; if a patient
felt unwell during exercise, a blinded physician examined the patient and reported the event.
This included chest pain, dizziness, suspected recurrence of AF, and musculoskeletal injuries.
2.7 Statistics
Prior to the analyses, data were entered blinded and validated by double entry. All analyses
were performed blinded and according to a pre-established analysis plan. Any deviation from
this plan is accounted for below (please see Deviations from the trial registration). Statistical
analyses were conducted using the STATA statistical software package version 13.1.
2.7.1 Descriptives. Baseline data were compared between intervention groups, HI and LI.
For demographics, Pearson χ2-test or Fisher’s exact test was performed for categorical vari-
ables, independent t-test or Wilcoxon rank-sum test was performed depending on distribu-
tion. Normally distributed data were presented with mean and standard deviation (SD), non-
parametric data with median and inter quartile range (IQR).
2.7.2 Primary outcome. Initially, Poisson regression was performed to analyze the differ-
ence in AF burden between exercise groups, but goodness of fit-test on deviance was poor
(P<0.0001). Under assumption of over-dispersed data, negative binomial regression analysis
was performed and confirmed (dispersion parameter = 2.7). The likelihood-ratio test strongly
suggested dispersion parameter6¼0, confirming that a negative binomial regression model was
a more appropriate fit. Results were reported as incidence rate ratio (IRR) for HI exercise com-
pared to LI exercise with 95% confidence intervals (95% CI). P-value of less than 0.05 was con-
sidered statistically significant for all primary and secondary analyses.
Before un-blinding data, six possible confounding variables were identified; age, gender,
LA volume, mean heart rate (24 hours), baseline peak VO2, and treatment with beta-blocker.
Each variable was evaluated by individual extraction from the full regression model, and con-
founding variables were kept in the adjusted regression analysis (LA volume, mean heart rate
and treatment with beta-blocker medication).
Both intention-to-treat (ITT) and per-protocol (PP) analyses were performed. All patients
who were randomized according to the opened envelopes were included in the ITT analysis,
Cardiovascular exercise and atrial fibrillation
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whereas patients participating in 2/3 (65%) of the exercise sessions were included in the PP
analysis.
Dose-response relationship between participation and AF burden was tested, as well as
effect modification by participation.
2.7.3 Secondary outcomes. Independent t-test was used to analyze change in peak VO2.
Two analyses were performed; one restricted to patients with ReR1.0 in combination with
sinus rhythm on ECG during the CPETs, and one analysis containing all participants. Hospital
admissions were analyzed with Fisher’s Exact Test or χ2-test when appropriate.
2.8 Deviations from the trial registration
Physical capacity was measured as peak VO2 instead of Six Minute Walk Test as described in
the protocol (S1 Clinical Trial Protocol). We got access to the equipment after designing the
study before start up and changed it due to the improved quality it added to the study.
The duration of each exercise session was 60 minutes instead of alternately 60 and 90 min-
utes for logistical reasons.
The study was registered at Clinical Trials three months after the first patient was included;
unfortunately we were unaware of the great importance of pre-registration. However, no
changes were made to the study during these three months.
Before analyzing data, it became clear that some patients transmitted several ECGs daily
without marking it as a symptomatic episode. To reduce possible information bias, burden of
AF was assessed additionally as number of days with AF on minimum one ECG. ITT analysis
was performed under the same conditions as the primary analysis of AF-ratio and likewise
reported as IRR with 95% CI.
To detect any time-dependent difference in first AF-episode after the exercise sessions
started, Cox proportional regression analysis was performed and reported as hazard ratios
(HR) with 95% CI for HI exercise compared to LI exercise.
Baseline data from cardiac ultrasound and 24-hour measurement of blood pressure/heart
rate is used for description of the study population. Follow-up data are part of more compre-
hensive analyses to be reported later, as well as quality of life. Blood samples were collected and
are stored in a freezer for future analyses. Reports on these data will hold a clear reference to
the primary trial and its trial identifier.
2.9 Sample size
An average rate of burden AF-episodes in patients with PAF is not known, and is difficult to
estimate. We assumed the LI group would have approximately 20 ECGs with AF during the
time of monitoring (week 4–16). A mean reduction in AF burden of 25% was considered the
least clinically relevant. Enrolling 60 patients would make it possible to detect this difference
and achieve a power of 90% for two-sided α = 0.05 (95% CI). Our sample size estimation was
based on an independent two-sample t-test. Taking into account an attrition rate of 20%, a
minimum of 72 patients needed to be included.
3. Results
3.1 Participant flow
In the primary screening of participants, 403 patients were found potentially eligible. Of these,
277 patients did not meet inclusion criteria after reviewing medical records. The remaining
126 patients were asked to participate; 50 patients declined mainly due to employment or
logistics (Fig 1). Overall, 76 patients were included, of these, 63 patients completed the full
Cardiovascular exercise and atrial fibrillation
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12-week exercise intervention. After randomization, seven patients were excluded for various
reasons; six patients were screening failures with permanent AF, and one patient was excluded
from analysis due to cardiac ablation. During the 12-week intervention time, six patients
dropped out; four patients did not receive intervention, of these, two patients never showed up
(allocated to LI exercise) and two patients had to withdraw their consent due to logistics (one
from each exercise group); two participants allocated to HI exercise discontinued intervention,
one due to concomitant disease and one due to logistics.
Fig 1. Patient flow diagram for low and high intensity physical exercise.
doi:10.1371/journal.pone.0170060.g001
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3.2 Recruitment
The study was carried out from 1st January 2013- 28th February 2015.
3.3 Baseline data
All variables, except treatment with vitamin K-antagonist, were equally distributed between
intervention groups (Table 1).
3.4 Outcomes
The reporting of ECGs was high; a total of 9,971 ECGs were transmitted from the population
of these 4,586 ECGs from LI exercise (98.3% being interpretable) and 5,385 ECGs from HI
exercise (98.9% being interpretable). Total number of AF episodes in the interpretable ECG’s
were n = 553 and n = 534 for LI and HI exercise, respectively. On average, each participant
reported median 1.9 ECGs/day (IQR 1.5–2.0) and 2 ECGs/day (IQR 1.5–2.1) for LI and HI
physical exercise, respectively.
3.4.1 Primary analysis for the primary outcome (ITT). In the unadjusted regression
analysis, the burden of AF was not statistically different between the exercise groups (IRR
0.983, 95% CI 0.39–2.46, P = 0.971), Fig 2. Similarly, after adjusting for predefined confound-
ers (LA volume, use of beta blocker, and baseline heart rate), the IRR decreased, but the effect
of HI exercise remained not statistically different from LI exercise (IRR 0.742, 95% CI 0.29–
1.91, P = 0.538).
Three patients differed considerably from the rest by having AF more than 95% of the time,
a condition very close to permanent AF. Excluding them from the analysis did not change the
overall outcome, IRR 0.89 (95% CI 0.37–2.14, P = 0.799). Participation did not modify the out-
come, IRR = 1.0 (95% CI 0.95–1.06, P = 0.442), and we found no dose-response relationship
between participation and AF burden, IRR = 1.02 (95% CI 0.99–1.05, P = 0.324).
3.4.2 Secondary analysis for the primary outcome (PP). In total, 52 patients fulfilled the
protocol with a minimum participation rate of 65% of all exercise sessions. Similar to the ITT-
analysis, the burden of AF was not statistically different between the exercise groups in the
adjusted PP analysis (IRR 0.81, 95% CI 0.28–2.31, P = 0.416), Fig 2.
3.4.3 Secondary analysis for the secondary outcomes. In the analysis of peak VO2, two
CPETs were excluded due to unrecognized disease during the test (pneumonia and erysipelas,
respectively). When considering CPET with ReR>1.0 and normal ECG, both groups improved
their peak VO2 significantly during the 12-week exercise, mean (LI) 3.62 mL O2/kg/min (SD
3.77), and mean (HI) 2.87 mL O2/kg/min (SD 4.98). We found no significant difference in
improvement of peak VO2 between the exercise groups (mean diff. -0.76 mL O2/kg/min, 95%
CI -3.22–1.70). Likewise, when including all CPET’s (mean diff. 0.07 mL O2/kg/min, 95% CI
-2.24–2.38).
During follow-up, 38 admissions were registered, Table 2. There was no difference in over-
all hospitalization for LI exercise compared to HI exercise. Admissions with recurrence of AF
were most frequent, but with no significant difference between LI and HI exercise, P = 0.465.
3.4.4 Ancillary analyses. Analyzing AF burden as number of days with AF, showed no
significant reduction in AF burden between HI and LI exercise (IRR 0.92, 95% CI 0.35–2.41,
P = 0.865), Fig 2.
We found no significant difference in time to first AF episode; patients exercising at HI did
not have their first AF episode later than patients exercising at LI (HR = 1.1, 95% CI 0.6–1.9,
P = 0.806).
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Table 1. Baseline characteristics of low and high intensity exercise groups.
Variable Level Low intensity (N = 33) High intensity (N = 37)
Gender Male 19 (57.6%) 22 (59.4%)
Race White 32 (97.0%) 36 (97.3%)
Age, years 63.8 (3.3) 61.4 (3)
Height, cm 177 (9) 178 (11)
BMI, kg/m2 30.1 (9.2) 29.1 (7.9)
Peak VO2, mL O2/kg/min 23.0 (9.7) 21.0 (6.9)
Tobacco Former 17 (51.5%) 18 (48.6%)
no 13 (39.4%) 12 (32.4%)
yes 3 (9.1%) 7 (18.9%)
Alcohol, National  30 (90.9%) 32 (86.5%)
Recommendationsa > 3 (9.1%) 5 (13.5%)
Habitual exercise, hours/week <1 h 16 (48.5%) 10 (27.0%)
1–3 h 13 (39.4%) 19 (51.4%)
3–6 h 3 (9.1%) 4 (10.8%)
>6 h 1 (3.0%) 4 (10.8%)
Type AF paroxysmal 18 (54.5%) 16 (43.2%)
persistent 15 (45.5%) 21 (56.8%)
Hypertension yes 16 (48.5%) 21 (56.8%)
Diabetes mellitus yes 4 (12.1%) 6 (16.2%)
Ischemic heart disease yes 2 (6.1%) 2 (5.4%)
Metabolic disease yes 3 (9.1%) 4 (10.8%)
COPD yes 1 (3.0%) 3 (8.1%)
Heart failure, yes 3 (9.1%) 0 (0%)
Medication
β-blocker yes 22 (66.7%) 23 (62.2%)
Ca2+-blocker yes 8 (24.2%) 11 (29.7%)
ACE+ARBb yes 9 (27.3%) 14 (37.8%)
Digoxin yes 2 (6.1%) 4 (10.8%)
1c anti arrhythmica yes 5 (15.2%) 11 (29.7%)
Novel Oral Anticoagulants yes 13 (39.4%) 11 (29.7%)
Vitamin K Antagonists yes 4 (12.1%) 17 (45.9%)
Acetylsalicylic Acid yes 3 (9.1%) 7 (18.9%)
Statins yes 14 (42.4%) 18 (48.6%)
Diuretics yes 7 (21.2%) 5 (13.5%)
LVEF <50% 4 (12.9%) 5 (14.3%)
50–59% 18 (58.1%) 17 (48.6%)
>60% 11 (35.5%) 13 (37.1%)
LA volumec, mL/m2 36.55 (29.3–43.9) 37.8 (28.2–42.5)
LViDd, cm 5.01 (0.58) 4.97 (0.61)
AF duration, monthsc 33.6 (10.9–62.2) 20.6 (7.7–54.3)
Heart rate, bpm 66 (10) 67 (12)
Blood pressurec, mmHg Day 125 (12) / 74 (8) 128 (13) / 73 (14)
Night 118 (16) / 66 (10) 118 (19) / 68 (10)
Participationc, % 87 (70–92) 87 (65–92)
(Continued )
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3.5 Adverse events
An adverse event was defined as any reported physical inconvenience during the exercise ses-
sions. In case the patients had symptoms that could be related to AF or otherwise needed med-
ical evaluation, they were examined by a blinded physician. If confirmed and considered of
significance in relation to the physical exercise it was reported as a major adverse event. In
total, nine patients were medically examined during the trial. No serious adverse events related
to the exercise sessions were registered. One patient paused exercise sessions shortly due to
increasing symptoms of arrhythmia, which in the later analysis turned out to be accumulation
of benign supraventricular ectopic activity (HI-group). Two patients were admitted to the hos-
pital after an exercise session due to AF recurrence; both episodes had started ahead of the ses-
sion and were not considered to be induced by the exercise (HI-group). Three patients had AF
ahead of an exercise session; two converted spontaneously (LI-group) and one had adjusted
the medical treatment (HI-group). Three patients had minor complaints proven to be non-
cardiac: one patient (HI-group) felt unspecific chest pain (chronic gastric reflux); one patient
felt dizzy (HI-group); one patient had temporary worsening of arthritis (LI-group).
4. Discussion
4.1 Principal findings
In this randomized controlled trial, we studied the effect of cardiovascular exercise on burden
of AF among patients with paroxysmal or persistent AF. Over 12 weeks, 76 patients participated
Table 1. (Continued)
Variable Level Low intensity (N = 33) High intensity (N = 37)
ECG totalc, n 161 (23–169) 164 (29–178)
Data presented as mean (SD) and number (%) if not otherwise stated
aRecommended intake in Denmark: Women7 units/week, men15 units/week
bACE = Angiotensin Converting Enzyme Inhibitor, ARB = Angiotensin-II Receptor Antagonist
cReported as median (IQR)
doi:10.1371/journal.pone.0170060.t001
Fig 2. Incidence Rate Ratio (IRR) for burden of atrial fibrillation, high compared to low intensity exercise. IRR<1
favors high intensity exercise.
doi:10.1371/journal.pone.0170060.g002
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in a program of either LI or HI physical exercise and assessed their heart rhythm daily. The
main finding was that HI exercise was not superior to LI exercise in reducing the burden of AF
during the exercise intervention period.
So far, most interventional exercise trials have included patients with permanent AF or
patients undergoing cardiac radiofrequency ablation. Cardiovascular exercise has been shown
to improve resting heart rate and to some extend reduce the need for medical treatment in
these patients [24–27]. After radiofrequency ablation, exercise as part of lifestyle changes has
improved the long-term maintenance of sinus rhythm [28]. One study has focused on daily
AF burden among patients with PAF measured by seven-day Holter monitoring and the AF
severity scale questionnaire [29]. The study was observational and found an association
between improved physical fitness and reduction in AF symptoms and arrhythmia on ECG.
The causal pathway between improved physical fitness and the cardiac impact of exercise is
not fully elucidated but includes changes in the autonomic regulation and remodeling of the
atrial wall. The balance between parasympathetic and sympathetic regulation of the heart is
important for preventing new episodes of AF [30,31]. While athletes often experience AF epi-
sodes triggered by a strong parasympathetic tone (e.g. in the relaxation phase after exertion),
most other AF patients are under influence of a relative high sympathetic tone, which makes
the atrium more susceptible to AF [30,32]. Regular physical exercise on a non-elite level
reverses the autonomic balance towards a stronger parasympathetic cardiac tone, and this
effect is suggested to improve rhythm regulation and prevention of AF episodes [24–28].
In our study, we could not confirm any clear difference in burden of AF between the two
exercise groups. The daily reporting of ECGs was good (median 1.9–2 ECGs/day), but the
average number of AF episodes was well below the expected (LI 50p = 3, IQR 0–14; HI
50p = 4, IQR 0–17). Of 63 analyzed patients, twenty patients had no AF at all (32%), so any dif-
ference became difficult to identify. It is possible the patients in general were healthier than
expected due to some degree of selection bias that can occur in a clinical trial, especially with
the possibility of being allocated to HI physical exercise. Moreover, using intermittent thumb
ECG (Zenicor1) increases the risk of underestimating AF burden compared to continuous
monitoring. Thumb ECG is easy to use for the patients, convenient and without any risks.
Compared with 24-hour Holter monitoring, intermittent thumb ECG recording during four
weeks has been proven more effective at detecting AF [33]. It could possibly discourage too
many patients to complete the trial if Holter monitoring had to be used for a longer period due
to the inconvenience of wearing it. The randomization procedure should ensure that a possible
underestimation affects the two exercise groups equally.
Table 2. Hospital admissions during follow-up for LI and HI physical exercise.
Low intensity High intensity
Follow-up time, days 448.5 (18.4) 426.6 (101.1)
Recurrent AF 17 (89.5%) 13 (68.4%) P = 0.465a
Ablation 0 (0%) 5 (26.3%)
Antiarrhythmic medical treatment 2 (10.5%) 0 (0%)
Heart failure, n (%) 0 (0%) 1 (5.3%)
Pacemaker implantation 0 (0%) 0 (0%)
Stroke 0 (0%) 0 (0%)
Total 19 (100%) 19 (100%)
Data presented as mean (SD) and number (%)
aχ2-test of admissions with recurrent AF for LI compared to HI exercise groups
doi:10.1371/journal.pone.0170060.t002
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A recent published trial by Malmo et al. found that AF burden was reduced after 12 weeks
of high-intensity cardiovascular exercise compared to passive (do as usual) controls [15]. The
study differed some from our study by including highly symptomatic patients and by compar-
ing the HI exercise-intervention with passive controls. The exercise volume was slightly larger
and AF burden was measured continuously by a loop recorder.
Our trial focused on studying the effect of different exercise intensities. Physical exercise
prevents other lifestyle diseases in a dose-response manner [34], but based on the increased
incidence of AF among elite athletes, it has been uncertain whether the same was applicable in
preventing r AF. In our study, we could not significantly show that HI exercise was superior to
LI exercise in reducing AF burden. Most likely, the difference in effect of LI and HI physical
exercise on AF burden is smaller than expected. If exercise was maintained beyond 12 weeks, a
beneficial effect on AF burden could possibly be more pronounced due to slow onset of a
favorable cardiac risk profile, weight loss, and further increased exercise capacity [7]. Another
explanation for our findings could be that the difference in exercise effect on AF burden does
not show because the patients achieved the same physiological effect of the exercise interven-
tion (peak VO2). However, peak VO2 was only assessed as a secondary validation of the exer-
cise effect and any firm conclusions on this relationship should be made with caution since we
do not know the exact relationship between change in VO2 and AF.
Both groups improved their physical fitness significantly to a level comparable with patients
from other cardiac rehabilitation programs (3–4 mL O2/min/kg) [35]. It was expected they
would improve more than patients with heart failure and ischemic heart disease. To our sur-
prise, we did not find that HI exercise improved the physical fitness more than LI exercise did.
Several factors can explain this outcome. The study was designed with a LI group, exercising at
50% of maximum perceived exertion, where only little improvement in fitness was expected.
For the participants, we issued no restrictions on their daily physical activity to make it compa-
rable to clinical practice. During the study, we experienced behavioral change among the
patients, e.g. going by bike instead of by car, because they felt more confident about exercising.
Moreover, it is possible that AF patients do not obtain the same additional effect on peak VO2
from the higher intensity. In the trial by Malmo et al., the effect of HI exercise on improvement
in peak VO2 was smaller than expected, 3.2 mL O2/min/kg (SD 2.5) [15]. We find it possible
that exercise has greater effect on rhythm control, even at lower intensities of exercise, than on
the improvement in physical fitness. As also discussed in the paper by Malmo et al. [15], medi-
cal rhythm control and recurrent AF episodes can possibly modify the physical performance
and reduce the expected additional effect seen in healthy individuals.
It was only possible to obtain partial blinding of the patients, and in some cases it was a
challenge to restrict the intensity to 50% for patients at the LI exercise. Patients interested in
physical exercise are more likely to volunteer to an exercise study and might be biased about
the beneficial effect of exercise. We tried to prevent this effect by carefully informing both
patients and the physiotherapists that we did not know which exercise intensity was most
favorable for AF patients.
We performed two analyses of peak VO2; one analysis restricted to patients free of AF dur-
ing the test and with a cut-off point at ReR1.00, and one analysis containing all tests. When
analyzing all CPETs together, the mean improvement in VO2 declined, possibly reflecting
inclusion of submaximal CPETs.
It is widely discussed which method is the best for assessing maximal physical fitness in
patients, since ReR is affected by high age, obesity, sedentary life style, and cardiac disease
[22,36]. Atwood et al. performed maximal exercise testing in 50 AF patients and achieved
mean ReR = 1.06 [37]. Until recently, patients with PAF was expected to have a normal exer-
cise capacity in sinus rhythm (if no underlying cardiac disease) [14,37], but new evidence
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suggests that AF patients can have reduced diastolic cardiac function thereby affecting maxi-
mal exercise capacity [35]. In lack of specific guidelines for exercise testing in AF-patients, we
relied on recommendations for cardiac rehabilitation exercise testing [22], and excluded the
tests from the analyses if AF was present.
Besides a tangible symptom relief, it is of consideration whether a smaller AF burden can
reduce the risk of serious complications as thromboembolic events or cardiomyopathy
induced by tachycardia. Observational studies suggest a higher risk of thromboembolic events
in patients with a high burden of AF [38–41], and directly in relation to prolonged AF episodes
[42]. We know that physical activity is associated with decreased mortality and cardiovascular
disease, and it would be intriguing to find out, if a reduction in AF burden could reduce the
risk of thromboembolic events additionally.
This study report important experiences to be used in future interventional studies;. for fur-
ther large scale studies, measuring both rhythm on ECG as well as symptoms on the AF sever-
ity scale questionnaire will be preferable. Several patients in this study expressed that their AF
episodes appeared less intense and of shorter duration, but we were not able to quantify that
information, given our focus on the objective measured AF burden.
In the daily clinic, advising patients with PAF about exercise and possible limitations has
been based primarily on observational studies and personal experience. It is a very heteroge-
neous patient group, and there are no formalized rehabilitation programs to offer. Our data
showed that the patients tolerated HI exercise well, without excess adverse events or hospital
admissionsand we do not find that the fear of worsening the arrhythmia should be an obstacle
to performing HI exercise for preventing further lifestyle diseases. However, we recognize the
need for confirming this in larger scale studies.
4.2 Strengths and limitations
This trial is the first randomized controlled trial in a clinical setting studying the effect of dif-
ferent cardiovascular exercise-intensities on burden of AF among patients with PAF. Assess-
ment of our primary outcome burden of AF was very detailed with daily measuring of the
cardiac rhythm and a high reporting rate. Both exercise participation and adherence to the
study were high.
Exercise was supervised by experienced physiotherapists, who trained both LI and HI,
thereby neutralizing the effects of any unequal expertise. Supervised exercise conducted at the
hospital eliminates the insecurity related to self-reported home exercise and increases adher-
ence. All participants received an intervention to equalize the positive effect of being in a trial.
The vast majority of the exercise tests were performed by the same technical assistants to
reduce difference in individual performance. No serious adverse events were related to the
exercise intervention.
The main limitation of our study is the low burden of AF and small sample size giving no
opportunity of making statistical significant conclusion. The unexpected improvement in
physical fitness for LI exercise illustrates the difficulties in administering the right dose of exer-
cise. Exercise testing is sensitive to psychological barriers and motivation, and there can be a
learning effect for the patient over time.
5. Conclusion
In this randomized controlled trial, 12 weeks of HI exercise was not superior to LI exercise in
reducing the primary outcome, burden of AF, among patients with PAF. HI exercise was well
tolerated; no evidence of an increased risk was found for HI compared to LI exercise. To main-
tain a healthy lifestyle, AF patients should perform physical exercise, however based on our
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findings it is not possible to provide any specific recommendations for AF patients and further
largescale studies with longer follow-up are needed.
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